Vitaccess Real CIDP Registry

  • Research type

    Research Database

  • IRAS ID

    361627

  • Contact name

    Ellie Bowmar

  • Contact email

    ellie.bowmar@vitaccess.com

  • Research summary

    Vitaccess Real CIDP Registry

  • REC name

    West of Scotland REC 5

  • REC reference

    25/WS/0145

  • Date of REC Opinion

    27 Oct 2025

  • REC opinion

    Further Information Favourable Opinion

  • Data collection arrangements

    The primary objective of the registry is to build a repository of data containing relevant outcomes in CIDP from both patients and clinical health records. Patients
    will contribute custom survey and validated patient-reported outcomes data via the
    digital data capture platform, which they can access on their own device (smartphone/tablet/computer/laptop). The platform will be deployed alongside a web-based electronic case report form (eCRF) platform for data capture from HCPs and existing medical records. The data provided via the eCRF and the patient will be linked via the unique ID and PIN that are created for each patient in the eCRF system prior to patient recruitment. All data collected will be identified in accordance with the protocol and validated PRO instruments and pseudonymized. All personally identifiable
    information (PII) will be protected by industry standard methods, ensuring full confidentiality is maintained. Registry data will be stored in secure servers, which will reduce any risk of data being compromised during storage. The
    infrastructure is in UK data centers and is International Organization for Standardization (ISO) 27001 and System and Organizational Controls (SOC) 1, 2, and 3 compliant. All servers are held securely behind a firewall and have been configured to current best practices. Access to the infrastructure is provided using multi-factor authentication. Software is tested for its ability to withstand outside intervention, which is validated regularly by carrying out third-party penetration testing. Database backups are carried out on a regular cycle and restore procedures are in place and
    tested regularly.

  • Research programme

    Vitaccess Real CIDP (VRCIDP) is a patient registry designed to capture longitudinal observational data on chronic inflammatory demyelinating polyneuropathy (CIDP), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). Adults (age ≥18 years) with a clinically-confirmed diagnosis of CIDP will be eligible to participate. The registry will link direct patient-reported data with data reported by healthcare professionals (HCPs) and from patients’ existing medical records. The purpose of the VRCIDP registry is to facilitate a range of research objective-driven registry-based studies to further understand the real-world impact of CIDP and its treatment – including the real-world pharmacoepidemiological study of novel therapies.

  • Research database title

    Vitaccess Real CIDP Registry

  • Establishment organisation

    Vitaccess Ltd

  • Establishment organisation address

    2nd Floor Nucleus House

    Richmond, London

    TW9 2JA